| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045617444 |
| P356 | DOI | 10.1038/SJ.BMT.1703258 |
| P698 | PubMed publication ID | 11753547 |
| P5875 | ResearchGate publication ID | 11603048 |
| P2093 | author name string | Lee DG | |
| Lee S | |||
| Lee JW | |||
| Kim YJ | |||
| Kim HJ | |||
| Lee WY | |||
| Kim CC | |||
| Kim DW | |||
| Min WS | |||
| Park YH | |||
| Min CK | |||
| Min DJ | |||
| P2860 | cites work | Interleukin-10 | Q28263225 |
| Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients | Q40721259 | ||
| Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes | Q58681791 | ||
| Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
| Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors | Q70314352 | ||
| Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation | Q73170745 | ||
| Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation | Q73446042 | ||
| Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver | Q73807520 | ||
| High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation | Q73810025 | ||
| High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths | Q77925510 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 935-940 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation | |
| P478 | volume | 28 |
| Q52860217 | A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation. |
| Q57734363 | Advances in the genomics of allogeneic haemopoietic stem cell transplantation |
| Q90441813 | Assessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantation |
| Q37162888 | Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation |
| Q35757981 | Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation |
| Q35883325 | Cytokines in tear fluid of patients with ocular graft-versus-host disease after allogeneic stem cell transplantation. |
| Q36006379 | Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation |
| Q54435011 | Different cytokine signatures in children with localized and invasive adenovirus infection after stem cell transplantation. |
| Q35209103 | Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. |
| Q41706699 | Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study |
| Q40269737 | Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients |
| Q41986469 | Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation |
| Q80933890 | IL-4-producing CD8(+) T cells may be an immunological hallmark of chronic GVHD |
| Q44915694 | Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation |
| Q35536376 | Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients |
| Q33774610 | Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target |
| Q59387658 | Investigation of Functional IL-10 Gene Polymorphism and IL-10 Levels in Acute Graft-Versus-Host Disease |
| Q34408137 | Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease |
| Q38625302 | Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation |
| Q35739133 | Low-level laser therapy prevents severe oral mucositis in patients submitted to hematopoietic stem cell transplantation: a randomized clinical trial |
| Q82363808 | Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse |
| Q35048308 | Potential use of porous titanium-niobium alloy in orthopedic implants: preparation and experimental study of its biocompatibility in vitro |
| Q37157282 | Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation |
| Q49228781 | Protein dysregulation in graft versus host disease |
| Q55191871 | Reply to Kontoyiannis. |
| Q53625994 | Role of platelet-derived chemokines (RANTES and ENA-78) after stem cell transplantation. |
| Q53516297 | Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation. |
| Q73437152 | Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses |
| Q42716642 | Selenium supplementation in patients undergoing hematopoietic stem cell transplantation: effects on pro-inflammatory cytokines levels |
| Q102141644 | Uncovering the multifaceted roles played by neutrophils in allogeneic hematopoietic stem cell transplantation |
| Q83919487 | Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation |
Search more.